United States · FDA National Drug Code directory
TEPMETKO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44087-5000_d922de79-b0f0-4ed2-b551-c7a86ed72d7d
- Product NDC
- 44087-5000
- Form
- TABLET
- Composition / generic term
- Tepotinib Hydrochloride
- Labeler
- EMD Serono, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210203
- Source listing expiry
- 20261231
Source-listed ingredients
- TEPOTINIB HYDROCHLORIDE — 225 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (44087-5000-3) / 10 TABLET in 1 BLISTER PACK · 44087-5000-3
- 6 BLISTER PACK in 1 CARTON (44087-5000-6) / 10 TABLET in 1 BLISTER PACK · 44087-5000-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →